title: TNF-alpha blockade with infliximab in a patient with lupus erythematosus profundus.
authors.affiliation: Department of Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, DE-01307 Dresden, Germany. claudia.guenther@uniklinikum-dresden.de
authors.forename: Claudia
authors.initials: C
authors.lastname: Günther
authors.forename: Martin
authors.initials: M
authors.lastname: Aringer
authors.forename: Marlene
authors.initials: M
authors.lastname: Lochno
authors.forename: Eva
authors.initials: E
authors.lastname: Kämmerer
authors.forename: Andrea
authors.initials: A
authors.lastname: Bauer
authors.forename: Gottfried
authors.initials: G
authors.lastname: Wozel
authors.forename: Michael
authors.initials: M
authors.lastname: Meurer
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001706:Biopsy; D005260:Female; D006801:Humans; D000069285:Infliximab; D015435:Panniculitis, Lupus Erythematosus / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D012720:Severity of Illness Index; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab